A Retrospective Analysis of PK and Response of Oral Ibuprofen in the Treatment of a Patent Ductus Arteriosus in Extremely Low Gestational Age Neonates
The Journal of Clinical Pharmacology · 2025
DOI: 10.1002/jcph.70033 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2025. Verfasst von Mohd Asif und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neonatal Intensive Care Unit, McMaster Children's Hospital, Hamilton, ON, Canada. Hauptthemen laut MEDLINE: Ibuprofen, Ductus Arteriosus, Patent, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Oral ibuprofen is the preferred pharmacotherapeutic option for treatment of a persistent patent ductus arteriosus (PDA), but evidence for its optimal use in extremely low gestational age newborns (ELGANs) remains limited. In the current study, we aimed to investigate the pharmacokinetics and exposure‐response relationship of oral ibuprofen in ELGANs of ≤72 h postnatal age (PNA) on standard (SD) versus those >72 h PNA on high‐dose (HD) regimen for closure of persistent PDA. This was a retrospective analysis of data from a previous population PK study of ELGANs with a persistent PDA treated with a SD (10–5–5 mg/kg/day, PNA 72 h) oral ibuprofen, with the primary aim of comparing degree of exposure, defined as AUC 0‐24 (AUC from time 0 to 24 h). Twelve ELGANs received SD versus 11 receiving HD oral ibuprofen. The mean (SD) of exposure at 24 h (AUC 0‐24 h ) was 486 (128) and 509 (208) ( P = .41) and at 72 h (AUC 0‐72 h ) was 1529 (493) and 1510 (820) ( P = .94). Two (16%) ELGANs in the HD group developed severe gastrointestinal (GI) AEs and 1 (9%) in the SD had severe intraventricular hemorrhage. The use of SD and HD oral ibuprofen in ELGANs with PNA of 72 h, respectively, resulted in comparable exposure. The PNA‐dependent response to oral ibuprofen and exposure‐response relationship in ELGANs of higher PNA needs further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neonatal Intensive Care Unit, McMaster Children's Hospital, Hamilton, ON, Canada.
- Faculty of Health Sciences, School of Nursing, McMaster University, Hamilton, ON, Canada.
- Department of Pediatrics, Monash University, Melbourne, VIC, Australia.
- Monash Newborn, Monash Children's Hospital, Melbourne, VIC, Australia.
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
- Department of Physiology & Pharmacology and Medicine (MR), University of Western Ontario, London, ON, Canada.
Zitieren
APA
Asif, M., Sushko, K., Razak, A., Borhan, S., Rieder, M., van den Anker, J., & Samiee-Zafarghandy, S. (2025). A Retrospective Analysis of PK and Response of Oral Ibuprofen in the Treatment of a Patent Ductus Arteriosus in Extremely Low Gestational Age Neonates. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70033
Vancouver
Asif M, Sushko K, Razak A, Borhan S, Rieder M, van den Anker J, et al. A Retrospective Analysis of PK and Response of Oral Ibuprofen in the Treatment of a Patent Ductus Arteriosus in Extremely Low Gestational Age Neonates. The Journal of Clinical Pharmacology. 2025. doi:10.1002/jcph.70033
BibTeX
@article{Asif2025,
author = {Asif, Mohd and Sushko, Katelyn and Razak, Abdul and Borhan, Sayem and Rieder, Michael and van den Anker, John and Samiee-Zafarghandy, Samira},
title = {A Retrospective Analysis of PK and Response of Oral Ibuprofen in the Treatment of a Patent Ductus Arteriosus in Extremely Low Gestational Age Neonates},
journal = {The Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/jcph.70033}
}
EUVIMED